Latest total liabilities for 7731.TWO: $390M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
MARX Biotech , Ltd. (7731.TWO) currently reports a total liabilities of $390M as of June 2026. That compares with $520M in the prior-year period — down 25.7% year over year. Use the charts on this page to explore MARX Biotech , Ltd.'s total liabilities history and peer comparisons.
MARX Biotech , Ltd.'s total liabilities decreased from $520M to $390M — a 25.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
MARX Biotech , Ltd. reported $390M in total liabilities as of June 2026. That compares with $520M in the prior-year period — down 25.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MARX Biotech , Ltd., and consider following 7731.TWO for alerts when major investors trade the stock.
MARX Biotech , Ltd. is classified in the Consumer Discretionary sector. On total liabilities, it currently shows $390M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing 7731.TWO with unrelated industries.